Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Akili Labs
AddedFeb 18, 2024
UpdatedJun 18, 2026
Akili Labs

Akili Labs

Pre-Seed

Akili Labs: A biomedical startup specializing in innovative medical diagnostic technology.

HQ
Baltimore, MD, US
Founded
2016
Overview
Compare
Fundraising
Employees

Akili Labs is a biomedical startup specializing in innovative medical diagnostic technology. The company aims to revolutionize healthcare by providing advanced diagnostic solutions that enhance the accuracy and efficiency of medical testing. Their products and services are designed to cater to a global market, addressing the needs of healthcare providers and patients alike.

Akili Labs has achieved significant milestones in the medical diagnostics field, contributing to improved patient outcomes and streamlined healthcare processes. Their cutting-edge technology has garnered attention and support from various stakeholders in the healthcare industry.

Akili Labs - Similar Companies

Akrivis Technologies logo

Akrivis Technologies

akrivis.com

Akila Labs logo

Akila Labs

akila.ai

Accelevir Diagnostics logo

Accelevir Diagnostics

Empowered Diagnostics logo

Empowered Diagnostics

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

BioAnalytics logo

BioAnalytics

Insightiv Technologies logo

Insightiv Technologies

Amplified Sciences logo

Amplified Sciences

Neuro42 logo

Neuro42

Accessible Diagnostics logo

Accessible Diagnostics

Test Diagnostics logo

Test Diagnostics

Bold Diagnostics logo

Bold Diagnostics

Retina-Ai Health logo

Retina-Ai Health

AlphaLab Health logo

AlphaLab Health

alphalabhealth.org

Airilabs logo

Airilabs

Akili Labs - Quick Facts

Who are Akili Labs' competitors?

Companies similar to Akili Labs include Akrivis Technologies, Akila Labs, Accelevir Diagnostics and Empowered Diagnostics.

When was Akili Labs founded?

Akili Labs was founded in 2016.

Where is Akili Labs' headquarters located?

Akili Labs' headquarters is located in Baltimore, MD, US.

When was Akili Labs' last funding round?

Akili Labs' most recent funding round was for $250k (USD) in February 2020.

How much has Akili Labs raised to-date?

As of Feb 3, 2020, Akili Labs has raised a total of $250k (USD).

How many employees does Akili Labs have?

Akili Labs has 11 employees as of Feb 5, 2024.

Akili Labs - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Diagnostics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified